(703) 627-1934


    8000 Towers Crescent Drive

    Suite 1388

    Vienna, VA 22182

    ©2019 by Sarfez Pharmaceuticals, Inc.

    Our Pipeline:
    Developing cardio-renal products

    We Improve Medications for Heart and Kidney Diseases

    Long-Acting Loop Diuretics

    Chronic Congestive Heart Failure

    Expected date of NDA approval Q1 2020

    Better Bioavailable Direct Renin Inhibitor


    Nephrotic Syndrome (FSGS) 

    Early clinical stage

    Expected NDA filing Q4 2020

    Improved Mineralocorticoid Receptor Antagonist

    Diabetic Nephropathy

    Early clinical stage

    Expected NDA filing Q1 2022

    Fast-Acting Mu Receptor Agonist


    Migraine Onset

    Late pre-clinical stage

    Expected NDA filing Q1 2022